http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#Head http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#assertion http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#provenance http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#pubinfo http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#assertion http://purl.obolibrary.org/obo/DOID_3078 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_3078 http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00853 http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association http://www.w3.org/2000/01/rdf-schema#label temozolomide capsules are an alkylating drug indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme gbm concomitantly with radiotherapy and then as maintenance treatment 1 1 refractory anaplastic astrocytoma patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine 1 2 temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment temozolomide capsules are indicated for the treatment of adult patients with refractory anaplastic astrocytoma i e patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00853 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#provenance http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#pubinfo http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#sig http://purl.org/nanopub/x/hasSignature fNfZrtG+k2qx5pKlQKatBfi44u1ikkOMfBSszrwbFXO4c8oDneCPxq09WFD8fL/AiamWX4NXHl2jmJ5KWpWJk0gsbCEqxCcuw6zT6Sz6AtAi8tn7hBIAllso8gIX7QoHnGqdzDsEjLPqJGIrmsVxThMmNYlOEoWqAVmB5vnjNA4= http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0 http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0 http://purl.org/dc/terms/created 2021-06-12T16:49:29.885+02:00 http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs